Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020223673 - VACCINATION USING HERPESVIRUS GENOMES IN NUCLEIC ACID FORM

Publication Number WO/2020/223673
Publication Date 05.11.2020
International Application No. PCT/US2020/031117
International Filing Date 01.05.2020
IPC
C12N 7/04 2006.01
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
7Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
04Inactivation or attenuation; Producing viral sub-units
A61K 39/245 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
12Viral antigens
245Herpetoviridae, e.g. herpes simplex virus
C07K 14/03 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005from viruses
01DNA viruses
03Herpetoviridae, e.g. pseudorabies virus
A61P 31/22 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12Antivirals
20for DNA viruses
22for herpes viruses
Applicants
  • THE REGENTS OF THE UNIVERSITY OF CALIFORNIA [US]/[US]
Inventors
  • HARTIGAN-O'CONNOR, Dennis
  • BARRY, Peter
  • DEERE, Jesse
  • DUTRA, Joseph
Agents
  • FOLLETTE, Peter J.
  • HAO, Joe C.
Priority Data
62/842,41902.05.2019US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) VACCINATION USING HERPESVIRUS GENOMES IN NUCLEIC ACID FORM
(FR) VACCINATION UTILISANT DES GÉNOMES D'HERPÈSVIRUS SOUS FORME D'ACIDE NUCLÉIQUE
Abstract
(EN)
The present invention provides compositions and methods for inducing immune responses in subjects using HV-based vectors that can be grown in single celled organisms and administered in their nucleic acid form.
(FR)
La présente invention concerne des compositions et des procédés pour induire des réponses immunitaires chez des sujets à l'aide de vecteurs à base de HV pouvant être cultivés dans des organismes unicellulaires et administrés sous leur forme d'acide nucléique.
Latest bibliographic data on file with the International Bureau